First case of DRESS syndrome attributed to a spider bite.

[1]  I. Hassan,et al.  Acute Generalized Exanthematous Pustulosis Due to Insect Bites? , 2015, Indian journal of dermatology.

[2]  Y. Yazdanpanah,et al.  Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV? , 2014, The British journal of dermatology.

[3]  J. Roujeau,et al.  Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist? , 2012, Orphanet Journal of Rare Diseases.

[4]  H. W. Fan,et al.  Spider bite , 2011, The Lancet.

[5]  P. Stoebner,et al.  [Necrotic arachnidism in the south of France: two clinical cases of loxoscelism]. , 2010, Annales de dermatologie et de venereologie.

[6]  L. Meunier,et al.  Envenimation nécrotique dans le Sud de la France : deux observations de loxoscélisme cutané , 2010 .

[7]  B. Sriha,et al.  Pustulose exanthématique aiguë généralisée succédant à une morsure d'araignée: trois observations tunisiennes , 2010 .

[8]  P. Temiz,et al.  Acute generalized exanthematous pustulosis with lymphangitis triggered by a spider bite , 2010, Cutaneous and ocular toxicology.

[9]  C. Belajouza,et al.  [Acute generalized exanthematous pustulosis following a spider bite: three cases from Tunisia]. , 2010, Annales de dermatologie et de venereologie.

[10]  A. Antoniadou,et al.  Acute generalized exanthematous pustulosis (AGEP) triggered by a spider bite. , 2009, Allergology international : official journal of the Japanese Society of Allergology.

[11]  M. Mockenhaupt,et al.  Variability in the clinical pattern of cutaneous side‐effects of drugs with systemic symptoms: does a DRESS syndrome really exist? , 2007, The British journal of dermatology.

[12]  S. Halevy,et al.  Acute generalized exanthematous pustulosis following a spider bite: report of 3 cases. , 2006, Journal of the American Academy of Dermatology.

[13]  O. Naderer,et al.  Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir. , 2001, Clinical therapeutics.